Abstract:Interleukin (IL)-6 is a pleiotropic cytokine that not only affects the immune system, but also acts in other biological systems and many physiological events in various organs. In a target cell, IL-6 can simultaneously generate functionally distinct or sometimes contradictory signals through its receptor complex, IL-6Rα and gp130. One good illustration is derived from the in vitro observations that IL-6 promotes the growth arrest and differentiation of M1 cells through gp130-mediated STAT3 activation, whereas the Y759/SHP-2-mediated cascade by gp130 stimulation has growth-enhancing effects. The final physiological output can be thought of as a consequence of the orchestration of the diverse signaling pathways generated by a given ligand. This concept, the signal orchestration model, may explain how IL-6 can elicit proinflammatory or anti-inflammatory effects, depending on the in vivo environmental circumstances. Elucidation of the molecular mechanisms underlying this issue is a challenging subject for future research. Intriguingly, recent in vivo studies indicated that the SHP-2-binding site- and YXXQ-mediated pathways through gp130 are not mutually exclusive but affect each other: a mutation at the SHP-2-binding site prolongs STAT3 activation, and a loss of STAT activation by gp130 truncation leads to sustained SHP-2/ERK MAPK phosphorylation. Although IL-6/gp130 signaling is a promising target for drug discovery for many human diseases, the interdependence of each signaling pathway may be an obstacle to the development of a nonpeptide orally active small molecule to inhibit one of these IL-6 signaling cascades, because it would disturb the signal orchestration. In mice, a consequence of the imbalanced signals causes unexpected results such as gastrointestinal disorders, autoimmune diseases, and/or chronic inflammatory proliferative diseases. However, lessons learned from IL-6 KO mice indicate that IL-6 is not essential for vital biological processes, but a significant impact on disease progression in many experimental models for human disorders. Thus, IL-6/gp130 signaling will become a more attractive therapeutic target for human inflammatory diseases when a better understanding of IL-6 signaling, including the identification of the conductor for gp130 signal transduction, is achieved.

IL-6-regulated transcription factors

Tnf-Alpha Induction Of Il-6 In Alveolar Type Ii Epithelial Cells: Contributions Of Jnk/C-Jun/Ap-1 Element, C/Ebp Delta/C/Ebp Binding Site And Ikk/Nf-Kappa B P65/Kappa B Site

IL-6 and NF-IL6 in acute-phase response and viral infection.

A nuclear factor for IL‐6 expression (NF‐IL6) is a member of a C/EBP family.

NF-IL6 and NF-κB in cytokine gene regulation

Constitutive and interleukin-1 (IL-1)-inducible factors interact with the IL-1-responsive element in the IL-6 gene

Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway

Macrophage differentiation-specific expression of NF-IL6, a transcription factor for interleukin-6

Identification and characterization of putative enhancer regions that direct Il6 transcription in murine macrophages

Phosphorylation at threonine-235 by a ras-dependent mitogen-activated protein kinase cascade is essential for transcription factor NF-IL6.

Nuclear Factor Interleukin 6 Motifs Mediate Tissue-specific Gene Transcription in Hypoxia*

Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8.

Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF)

Jak-STAT pathway is involved in the induction ofTNF-β gene during stimulation by IL-2

Identification of Novel Il-4/Stat6-Regulated Genes in T Lymphocytes

Transcription factors of the NFAT family: regulation and function.

Fos and Jun repress transcription activation by NF-IL6 through association at the basic zipper region

Unphosphorylated Stat3 Accumulates In Response To Il-6 And Activates Transcription By Binding To Nf Kappa B

IL-6 signal transduction and its physiological roles: the signal orchestration model

A novel LPS-inducible C-type lectin is a transcriptional target of NF-IL6 in macrophages

Essential role of Stat6 in IL-4 signalling